Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New web tool aims to ease tough ICU decisions for families of older patients

NCT ID NCT05019261

Knowledge-focused Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a web-based tool to support family members who make medical decisions for critically ill older adults unable to speak for themselves. The tool provided information about the ICU, helped families prepare for meetings with doctors, and shared their questions and concerns with the care team. The goal was to improve how well care matches the patient's wishes and to reduce stress for family members.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,039 people

The number who actually took part.

Started

Nov 2021

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

INCLUSION Patient 1. Age ≥18 2. Lack of decision-making capacity as determined by clinical examination by the attending physician or designee 3. Clinical indication of at least 40% risk of death or ≥40% chance of new, severe long-term functional impairment (needs assistance with ≥ 2 ADLs), as judged by the patient's attending physician or designee Surrogate 1. The primary surrogate is determined by the patient's advance directive or, if no directive exists, by following the hierarchy of surrogates codified in state law. 2. Up to 3 additional surrogates Clinician 1\. Patient's primary attending (or their designee) EXCLUSION Patient 1. Lack of a surrogate decision maker 2. Family not available for study 3. Imminent death (within 24 hours); goals of care are already "comfort measures only"; decision to withdraw life support has already been made 4. Currently participating in a competing research study that does not allow co-enrollment 5. Incarcerated or on an involuntary hold 6. Died prior to enrollment 7. Discharged prior to enrollment 8. Regained capacity prior to enrollment 9. Physician declined patient's participation 10. Physician and designee declined own participation 11. Patient does not meet inclusion criteria within 5 days of ICU admission 12. MD expects transfer orders will be written or the patient will be transferred within 36 hours of screening 13. Greater than 5 ICU days during the current hospitalization Surrogate 1. Age \<18 years 2. Cannot read or understand English 3. Cannot complete questionnaires due to physical or cognitive limitations 4. Has no access to or cannot travel to access the internet

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critical illness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Critical illness

Contacts and locations

Locations

  • Baystate Medical Center

    Springfield, Massachusetts, 01199, United States

  • Duke University

    Durham, North Carolina, 27710, United States

  • NYC Health + Hospitals/Lincoln Hospital

    New York, New York, 10451, United States

  • Oregon Health and Science University

    Portland, Oregon, 97239, United States

  • Pittsburgh VA Medical Center

    Pittsburgh, Pennsylvania, 15240, United States

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27599, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.